Market Share of Mexico Diabetes Drugs Industry
The Mexico Diabetes Drugs Market is moderately consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.
Mexico Diabetes Drugs Market Leaders
AstraZeneca
Novo Nordisk
Boehringer Ingelheim
Eli Lilly and Company
Sanofi Aventis
*Disclaimer: Major Players sorted in no particular order
